MB-001

· Mage Biologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MB-001, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis [Phase 1, Phase 2]